JPH0363207A - Skin cosmetic - Google Patents

Skin cosmetic

Info

Publication number
JPH0363207A
JPH0363207A JP20105789A JP20105789A JPH0363207A JP H0363207 A JPH0363207 A JP H0363207A JP 20105789 A JP20105789 A JP 20105789A JP 20105789 A JP20105789 A JP 20105789A JP H0363207 A JPH0363207 A JP H0363207A
Authority
JP
Japan
Prior art keywords
skin
effects
ascorbic acid
component
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20105789A
Other languages
Japanese (ja)
Inventor
Kyotaro Hasunuma
蓮沼 喬太郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP20105789A priority Critical patent/JPH0363207A/en
Publication of JPH0363207A publication Critical patent/JPH0363207A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain a skin cosmetic capable of simultaneously developing and providing excellent beautifying effects and inhibitory effects on skin aging, containing phosphoric ester magnesium salt of L-ascorbic acid and/or sulfuric ester sodium salt of L-ascorbic acid and gamma-aminobutyric acid. CONSTITUTION:A skin cosmetic which comprises one or more compounds selected from phosphoric ester magnesium salt of L-ascorbic acid and sulfuric ester sodium salt of L-ascorbic acid and (B) gamma-aminobutyric acid as essential components in the ratio of usually 0.01-30wt.% component A and 0.01-10wt.% component B, preferably 0.1-10wt.% component A and 1-5wt.% component B based on the total amounts of prescription components of cosmetic, has neither side effects not suitable to human body nor skin irritation, is stable even by long-term preservation and can simultaneously develop and provide chapped skin preventing effects, inhibitory effects on skin aging and beautifying effects by synergistic effects of both the components.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、L−アスコルビン酸リン酸エステルマグネシ
ウム塩及びL−アスコルビン酸硫酸エステルナトリウム
塩より選ばれた少なくとも1種以上の化合物並びにγ−
アミノ酪酸を含有してなる皮膚化粧料に関し、更に詳し
くは、人体に好ましくない副作用や皮膚刺激を有さす、
長期保存しても安定で、しかも優れた肌荒れ防止効果、
皮膚の老化防止効果および優れた美白効果を同時に発現
し、付与し得る皮膚化粧料に関する。
Detailed Description of the Invention [Industrial Application Field] The present invention provides at least one compound selected from L-ascorbic acid phosphate magnesium salt and L-ascorbic acid sulfate sodium salt, and γ-
Regarding skin cosmetics containing aminobutyric acid, more specifically, skin cosmetics containing aminobutyric acid, which have undesirable side effects and skin irritation on the human body,
Stable even after long-term storage, with excellent skin roughness prevention effect.
The present invention relates to a skin cosmetic that can simultaneously express and provide skin anti-aging effects and excellent whitening effects.

〔従来の技術及び発明が解決しようとする!1id)従
来、日焼けした肌を健常な肌色に回復するには、増加形
成しているメラニン色素の淡色漂白やメラニン生成過程
でチロシナーゼ活性の阻害等が必要であるとされている
[Conventional techniques and inventions try to solve the problem! 1id) Conventionally, in order to restore sunburned skin to a healthy complexion, it has been thought that it is necessary to lighten the increasing amount of melanin pigment formed and to inhibit tyrosinase activity during the melanin production process.

アスコルビン酸がこれらの作用を有し、皮膚の美白化、
しみ、そばかす、黒皮症等の治療改善に有効な化合物で
あることは周知であるが、化粧料に応用した場合、経口
安定性に問題があったり、変色、変臭の原因になり易い
。そのためアスコルビン酸を安定化する目的で、アスコ
ルビン酸を高級脂肪酸やリン酸などのエステル体として
配合したり、抗酸化剤、還元剤を使用添加することが提
案されているが、アスコルビン酸を安定化すればする程
、美白効果が薄れるといった問題点があった。
Ascorbic acid has these effects, skin whitening,
It is well known that this compound is effective in improving the treatment of age spots, freckles, melasma, etc. However, when applied to cosmetics, it may have problems with oral stability or easily cause discoloration and odor. Therefore, in order to stabilize ascorbic acid, it has been proposed to blend ascorbic acid as an ester with higher fatty acids or phosphoric acid, or to add antioxidants and reducing agents. There was a problem that the more you use it, the more the whitening effect will fade.

また、T−アミノ酪酸は、皮膚組va賦活作用により皮
膚機能を冗進し、皮膚老化防止効果を有することを見出
し提案した(特開昭51−148041号公報〉、シか
しγ−アξ)酪酸のみ配合してなる皮膚化粧料は、老化
防止等の効果は遅効性で、例えばクリームの場合では6
ケ月後に、ローションの場合は3ケ月後に効果が現れる
というように充分満足し得るものではなく、改良の余地
を残していた。
In addition, T-aminobutyric acid has been found to enhance skin functions by activating skin tissue VA and has anti-aging effects on the skin (Japanese Unexamined Patent Publication No. 148041/1989), and proposed that ) Skin cosmetics containing only butyric acid have delayed effects such as anti-aging; for example, in the case of cream,
In the case of the lotion, the effect appeared after 3 months, which was not completely satisfactory and left room for improvement.

本発明は優れた美白効果と皮膚老化防止効果とを同時に
発現、付与し得る優れた皮膚化粧料を提供することを目
的としている。
An object of the present invention is to provide an excellent skin cosmetic that can simultaneously exhibit and provide an excellent whitening effect and an anti-aging effect on the skin.

〔X1!題を解決するための手段〕 本発明はL−アスコルビン酸リン酸エステルマグネシウ
ム塩及びL−アスコルビン酸硫酸エステルナトリウム塩
より選ばれた少なくとも1種以上の化合物並びにγ−ア
くノ酪酸を含有してなる皮膚化粧料である。
[X1! Means for Solving the Problems] The present invention provides a compound containing at least one compound selected from L-ascorbic acid phosphate magnesium salt and L-ascorbic acid sulfate sodium salt, and γ-acnobutyric acid. It is a skin cosmetic.

本発明に用いるし一アスコルビン酸リン酸エステルマグ
ネシウム塩及びL−アスコルビン酸硫酸エステルナトリ
ウム塩(以下L−アスコルビン酸t’A iX体と略記
する)は公知の物質であり、その配合■は、化粧料の処
方成分全量を基準として(以下同様)iffl常0.0
1〜30重量%、好ましくは0、1〜10重量%の範囲
内である。
Mono-ascorbic acid phosphate magnesium salt and L-ascorbic acid sulfate sodium salt (hereinafter abbreviated as L-ascorbic acid t'A iX form) used in the present invention are known substances, and their formulation Iffl is always 0.0 based on the total amount of prescription ingredients (hereinafter the same)
It is in the range of 1 to 30% by weight, preferably 0.1 to 10% by weight.

本発明に用いるγ−アミノ酪酸(以下GABAと略記す
る)は公知物質であり、その配合量は0.01−10重
量%、好ましくは1〜5重量%の範囲内である。
γ-Aminobutyric acid (hereinafter abbreviated as GABA) used in the present invention is a known substance, and its amount is in the range of 0.01 to 10% by weight, preferably 1 to 5% by weight.

これら各々の配合量の上限を超えても、その超えた配合
量に見合った効果は期待出来ず、また、下限未満の配合
量では本発明の目的を達成することができない。
Even if the upper limit of each of these amounts is exceeded, no effect commensurate with the exceeded amount can be expected, and if the amount is less than the lower limit, the object of the present invention cannot be achieved.

本発明の皮膚化粧料の剤型としてはクリーム、乳液、化
粧水、パンク、パウダー等があげられ、上記原料の他に
色素、香料、防腐剤、界面活性剤、顔料、抗酸化剤等を
本発明の目的を達成する範囲内で適宜配合することがで
きる。
Forms of the skin cosmetics of the present invention include creams, emulsions, lotions, punctures, powders, etc. In addition to the above raw materials, pigments, fragrances, preservatives, surfactants, pigments, antioxidants, etc. They can be blended as appropriate within the range that achieves the purpose of the invention.

〔実施例〕〔Example〕

以下実施例について説明する。尚、実施例に示す%とは
重量%である。尚、実施例に記載の角質層のターンオー
バー速度測定方法、荒れ肌改善効果の測定試験法、角質
改善効果の測定試験法、官能テスト、皮膚色明度回復試
験法は下記の通りである。
Examples will be described below. Note that the percentages shown in the examples are percentages by weight. The methods for measuring the turnover rate of the stratum corneum, the test method for measuring the rough skin improvement effect, the test method for measuring the corneum improvement effect, the sensory test, and the skin color brightness recovery test method described in the Examples are as follows.

(1)  角質層のターンオーバー速度測定方法蛍光色
素のダンジルクロライドを白色ワセリン中に5vyt%
配合した軟膏を作り、被験者の前腕部の皮膚に24時間
閉蓋貼布し、角質層にダンジルクロライドを浸透結合さ
せる。その後同じ部位に1日2回(朝、夕)被験試料を
塗布し、毎日ダンジルクロライドの蛍光をしらぺ、その
蛍光が消滅するまでの日数を皮膚角質層のターンオーバ
ー速度とした。なお、il常の皮膚角質層のターンオー
バー速度は、14〜16日であるが、老化した皮膚にお
いては18日前後にのびる。それに対して老化防止効果
が現れると12日前後にまで短縮される。
(1) Method for measuring the turnover rate of the stratum corneum Add 5 vyt% of the fluorescent dye danzyl chloride to white petrolatum.
A blended ointment is made and applied to the skin of the subject's forearm with a lid closed for 24 hours to allow danzyl chloride to penetrate and bind to the stratum corneum. Thereafter, the test sample was applied to the same area twice a day (morning and evening), the fluorescence of danzyl chloride was monitored every day, and the number of days until the fluorescence disappeared was defined as the turnover rate of the skin stratum corneum. Note that the normal turnover rate of the skin's stratum corneum is 14 to 16 days, but in aged skin it increases to around 18 days. On the other hand, if the anti-aging effect appears, the time will be shortened to around 12 days.

(2)  荒れ肌改善効果の測定試験法下脚に荒れ肌を
有する中高年被験者20名を対象として4週間連続塗布
効果を調べた。被験者の左側下脚試験部位に1日2回約
1gの試料を塗布し、試験開始前および終了後の皮膚の
状態を下記の判定基準により判定した。右側下脚は試料
を塗布せず対照とした。
(2) Test method for measuring the effect of improving rough skin The effect of continuous application for 4 weeks was investigated on 20 middle-aged and elderly subjects with rough skin on their lower legs. Approximately 1 g of the sample was applied to the test site of the left lower leg of the subject twice a day, and the condition of the skin before and after the test was judged according to the following criteria. No sample was applied to the right lower leg, which served as a control.

皮膚乾燥度の判定基準 :正常 ± :軽微乾燥、落屑なし + :乾燥、落屑軽度 ++:乾燥、落屑中等度 +++:乾燥、落屑顕著 試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば+→−2
++→±)を「有効」、1段階改善された場合を「やや
有効」、変化がなかった場合を「無効」とした、試験結
果は「有効」、「やや有効」となった被験者の人数で示
した。
Judgment criteria for skin dryness: Normal±: Slight dryness, no flaking+: Mild dryness, flaking++: Moderate dryness, flaking+++: Significant dryness, flaking Comparing the judgment results of the test site and control site before and after the test, skin If the dryness has improved by two or more steps (e.g. +→-2)
++→±) is considered “effective,” one level of improvement is considered “somewhat effective,” and no change is considered “ineffective.” The number of subjects whose test results were “effective” or “slightly effective.” It was shown in

(3)  角質改善(角質細胞の抗剥離性増大〉効果の
測定試験法 前述の荒れ肌改善測定試験開始前および終了後の被験部
皮膚にスコッチテープにチバンメンデ、イングテーブ)
を接着し、これを1y111離した時テープに付着した
角質細胞の状態を走査型電子顕微鏡によって詳細に調べ
、下記の判定基準によって皮膚角質細胞抗I!1IIj
ll性を分離し、角質改善効果を求めた。
(3) Test method for measuring the effect of improving keratin (increasing the anti-exfoliation property of keratinocytes) Scotch tape was applied to the skin of the test area before and after the above-mentioned rough skin improvement measurement test.
When the tape was separated by 1y111, the state of the corneocytes attached to the tape was examined in detail using a scanning electron microscope. 1IIj
ll properties were separated and the keratin improving effect was determined.

角質改善効果(角質細胞抗剥離性増大)の判定基準 評価点1ニスケールを認めず 2:小スケール点在 3:小〜中スケール顕著 〃 4:大スケール顕著 判定は4週間連続塗布後の試験部位の評価点と対照部位
のそれとの差が2点以上の場合を「有効」、を点の場合
を「やや有効」、0点の場合を「無効」とした。試験結
果は「有効」、「やや有効Jとなった′d1.験者の人
数で示した。
Judgment criteria for keratin improving effect (increased anti-desquamation property of keratinocytes) Evaluation points: 1 No two scales observed 2: Small scales dotted 3: Small to medium scales noticeable 4: Large scales noticeable on test areas after 4 weeks of continuous application A case where the difference between the evaluation score and that of the control site was 2 or more points was considered "effective," a case where the difference was 2 points or more was considered "somewhat effective," and a case where the difference was 0 points was "ineffective." The test results were ``effective'' and ``slightly effective''.

(4)  官能テスト(美肌効果試験)荒れ肌、小じわ
、乾燥肌等を訴える女子被験者(35へ・55才)20
人に試料を182回(朝夕)連続3ケ月間塗布して、1
,2.3ケ月後の効果を評価した。試験結果は、皮膚の
湿潤性、平滑性、弾力性の各項目に対して、「皮膚に潤
いが生じた」、「皮膚が滑らかになった」、「皮膚に張
りが生じた」と回答した人数で示した。
(4) Sensory test (skin beautification effect test) 20 female subjects (35 to 55 years old) complaining of rough skin, fine wrinkles, dry skin, etc.
The sample was applied to a person 182 times (morning and evening) for three consecutive months.
, the effects were evaluated after 2.3 months. The test results showed that the skin felt moisturized, the skin became smoother, and the skin became taut in response to skin moisturization, smoothness, and elasticity. Shown in number of people.

さらに効果が現れるまでのM間も示した。Furthermore, the M period until the effect appears is also shown.

(5)  皮膚色明度回復試験法 被験者20名の背部皮膚にUV−B領域の紫外線を最小
紅斑量の2倍照射し、試料塗布部位と非塗布部位とを設
定して各々の皮7Hの基準明度(Vo値、Vo’値)を
測定した。引き続いて塗布部位には試料を1日2回ずつ
3ケ月間連vc塗布し、3,8.13週間後の塗布部位
及び非塗布部位の皮i明度(Vn値、Vn’値)を測定
して、下記の判定基準により皮膚色の回復評価を実施し
た。
(5) Skin color brightness recovery test method: The back skin of 20 subjects was irradiated with ultraviolet rays in the UV-B region twice the minimum amount of erythema, and sample application areas and non-application areas were set, and each skin 7H standard was determined. The brightness (Vo value, Vo' value) was measured. Subsequently, the sample was VC applied to the application site twice a day for 3 months, and the skin brightness (Vn value, Vn' value) of the application site and non-application site was measured after 3, 8 and 13 weeks. The recovery of skin color was evaluated using the following criteria.

尚、皮膚の明度(マンセル表色系V値)は高速分光色彩
計で測定して得られたxyz値より算出した。また、評
価は被験者20名の13a間後の+l)   Mi戒 実施例1〜5.比較例1〜3 Co/w型スキンクリーム〕 L−アスコルビン酸誘導体とGABAを下記の組成にお
いて配合して各々のO/ w型スキンクリームを調整し
前記の諸試験を実施した。
In addition, the brightness of the skin (Munsell color system V value) was calculated from the xyz values obtained by measurement with a high-speed spectrocolorimeter. In addition, the evaluation was conducted after 13a of 20 subjects +l) Mi Precept Examples 1 to 5. Comparative Examples 1 to 3 Co/w type skin cream] Each O/w type skin cream was prepared by blending an L-ascorbic acid derivative and GABA in the following composition, and the various tests described above were conducted.

尚、L−アスコルビン酸リン酸エステルマグネシウム塩
はVCPMgと、L−アスコルビン酸硫酸エステルナト
リウム塩はVC5Naと略記する。
In addition, L-ascorbic acid phosphate ester magnesium salt is abbreviated as VCPMg, and L-ascorbic acid sulfate ester sodium salt is abbreviated as VC5Na.

(2)  調整方法 (A)を70℃(B)を50℃にて均一に溶解しくA)
を撹拌しながら(B)を(A)に注入して乳化分散した
後、撹拌しながら温度30°Cまで冷却して調製する。
(2) Adjustment method: Dissolve (A) uniformly at 70°C (B) at 50°C (A)
The mixture is prepared by pouring (B) into (A) while stirring to emulsify and disperse, and then cooling to a temperature of 30°C while stirring.

(3)  特性 各0 / w型スキンクリームの諸試験を実施した結果
を第1表に示す。
(3) Characteristics Table 1 shows the results of various tests conducted on each 0/w type skin cream.

第1表に示すごとく比較例1〜3のL−アスコルビン酸
誘導体もしくはGABAを単独で配合した又は何れも配
合しなかったO / w型スキンクリームは諸特性にお
いて充分なる効果は得られず、本発明の実施例1〜5の
L−アスコルビン61誘導体及びGABAを配合したO
 / w型スキンクリームは諸特性において顕著な効果
が見られ、官能テストでは試料塗布後1〜2ケ月で優れ
た美肌効果実施例6〜8.比較例4〜6 (w10スキンクリーム〕 実施例1と同様に、下記の組成において各々のW10型
スキンクリームを調整し諸試験を実施した。
As shown in Table 1, the O/W type skin creams of Comparative Examples 1 to 3 containing L-ascorbic acid derivatives or GABA alone or containing neither of them did not have sufficient effects in terms of various properties; O containing L-ascorbine 61 derivatives and GABA of Examples 1 to 5 of the invention
/ The W-type skin cream showed remarkable effects in various properties, and in the sensory test, it showed excellent skin beautification effects 1 to 2 months after applying the sample.Examples 6 to 8. Comparative Examples 4 to 6 (W10 Skin Cream) Similarly to Example 1, W10 type skin creams having the following compositions were prepared and various tests were conducted.

fll  &[l威 冷却して調製する。flll & [lwei Cool and prepare.

(3)  特性 各W10型スキンクリームの諸試験を実施した結果を第
2表に示す。
(3) Characteristics Table 2 shows the results of various tests conducted on each W10 type skin cream.

第2表に示すごとく、比較例6〜8のL−アスコルビン
酸誘導体もしくはGABAを単独で配合した又は何れも
配合しなかったW/○型スキスキンクリーム特性におい
て充分なる効果は得られず、本発明の実施例4〜6のL
−アスコルビンrJ1.誘導体及びGABAを配合した
w / O型スキンクリームは諸特性において顕著な効
果が見られ、官能テストでは試料塗布後1〜2ケ月で優
れた美肌効果(2111整方法 (A)を70℃(B)を50℃にて、均一に溶解しくA
)を撹拌しながら(B)を(A)に注入して乳化分散し
た後、撹拌しながら温度30’Cまで実施例9〔乳酸〕 +11  &Il戒 がら温度30℃まで冷却して調製する。
As shown in Table 2, sufficient effects were not obtained in the properties of the W/○ type ski skin creams in Comparative Examples 6 to 8, in which L-ascorbic acid derivatives or GABA were blended alone or in which neither of them were blended. Examples 4 to 6 of the invention
-Ascorbine rJ1. The w/O type skin cream containing derivatives and GABA has remarkable effects on various properties, and in a sensory test, it showed excellent skin beautification effects (2111 skin care method (A) at 70℃ (B) 1 to 2 months after applying the sample. ) at 50℃ to uniformly dissolve A
) is poured into (A) while stirring to emulsify and disperse it, and then cooled to a temperature of 30° C. while stirring.

(3)  特性 得られた乳液は前記諸試験において良好な結果を示した
(3) Characteristics The obtained emulsion showed good results in the various tests mentioned above.

実施例10 〔化粧水〕 (1)  処方 (2)  調整方法 (A)を70℃(B)を50℃にて均一に溶解しくA)
を撹拌しながら(B)を(A)に注入して乳化分散した
後、取分(C)を加え、撹拌しな(2)  調整方法 (A)   (B)をそれぞれ常温で混合溶解しくB)
に(A)を加えて撹拌し調製する。
Example 10 [Lotion] (1) Prescription (2) Preparation method (A) to be uniformly dissolved at 70°C (B) at 50°C A)
Pour (B) into (A) while stirring and emulsify and disperse, then add fraction (C) and without stirring (2) Preparation method (A) Mix and dissolve (B) at room temperature. )
Prepare by adding (A) to and stirring.

(3)  特性 得られた化粧水は前記諸試験において良好な結果を示し
た。
(3) Characteristics The obtained lotion showed good results in the various tests mentioned above.

〔発明の効果〕〔Effect of the invention〕

本発明は、以上説明したように構成されてし)るので以
下に記載されるような効果を奏する。
Since the present invention is configured as described above, it produces the effects described below.

L−アスコルビン酸リン酸エステルマグネシウム塩、L
−アスコルビン酸硫酸エステルナトリウム塩より1ばれ
た少なくとも一種以上の化合物とγ−アミノ酪酸とを化
粧料に含有すると、両者による相乗効果によって美白効
果が増大し、皮膚老化防止効果が使用開始後1〜2ケ月
目とし1う極めて短期間で発現し、かつ持続することが
明らかである。
L-ascorbic acid phosphate ester magnesium salt, L
- When cosmetics contain at least one compound derived from ascorbic acid sulfate sodium salt and γ-aminobutyric acid, the whitening effect increases due to the synergistic effect of the two, and the skin aging prevention effect increases from 1 to 10 days after the start of use. It is clear that the disease appears in a very short period of time, such as the second month, and that it persists.

Claims (1)

【特許請求の範囲】[Claims] L−アスコルビン酸リン酸エステルマグネシウム塩及び
L−アスコルビン酸硫酸エステルナトリウム塩より選ば
れた少なくとも1種以上の化合物並びにγ−アミノ酪酸
を含有してなる皮膚化粧料。
A skin cosmetic comprising at least one compound selected from L-ascorbic acid phosphate magnesium salt and L-ascorbic acid sulfate sodium salt, and γ-aminobutyric acid.
JP20105789A 1989-08-01 1989-08-01 Skin cosmetic Pending JPH0363207A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20105789A JPH0363207A (en) 1989-08-01 1989-08-01 Skin cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20105789A JPH0363207A (en) 1989-08-01 1989-08-01 Skin cosmetic

Publications (1)

Publication Number Publication Date
JPH0363207A true JPH0363207A (en) 1991-03-19

Family

ID=16434679

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20105789A Pending JPH0363207A (en) 1989-08-01 1989-08-01 Skin cosmetic

Country Status (1)

Country Link
JP (1) JPH0363207A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05194178A (en) * 1992-01-21 1993-08-03 Kanebo Ltd Skin-beautifying cosmetic
WO1999013819A3 (en) * 1997-09-19 1999-06-03 E L Management Corp Composition and method for reducing stinging in skin
KR20020094130A (en) * 2001-06-11 2002-12-18 에이앤오 물산 주식회사 Once lighter be inside of an accessory
JP2003104863A (en) * 2001-09-28 2003-04-09 Kose Corp Liquid cosmetic
JP2010511021A (en) * 2006-11-30 2010-04-08 コーエン,マルセル Use of gamma aminobutyric acid as a depigmenting agent.

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05194178A (en) * 1992-01-21 1993-08-03 Kanebo Ltd Skin-beautifying cosmetic
WO1999013819A3 (en) * 1997-09-19 1999-06-03 E L Management Corp Composition and method for reducing stinging in skin
KR100453135B1 (en) * 1997-09-19 2004-10-15 이-엘 매니지먼트 코포레이션 Composition and Method for Reducing Stinging in Skin
KR20020094130A (en) * 2001-06-11 2002-12-18 에이앤오 물산 주식회사 Once lighter be inside of an accessory
JP2003104863A (en) * 2001-09-28 2003-04-09 Kose Corp Liquid cosmetic
JP2010511021A (en) * 2006-11-30 2010-04-08 コーエン,マルセル Use of gamma aminobutyric acid as a depigmenting agent.

Similar Documents

Publication Publication Date Title
JPS61152613A (en) Skin cosmetic
JPH0363207A (en) Skin cosmetic
JPS61207312A (en) Skin-beautifying cosmetic
JPS6281307A (en) Skin cosmetic
JPH08291039A (en) Skin-lightening cosmetic
JPH0363211A (en) Cosmetic for fair skin and beauty
JP3354768B2 (en) Skin cosmetics
JPS62164609A (en) Skin cosmetic
JPH07112966B2 (en) Skin cosmetics
JPH01100112A (en) External preparation for skin
JP3045604B2 (en) Whitening cosmetics
JPH02138108A (en) Skin cosmetic
JPH01121205A (en) Skin beautifying cosmetic
JP3133508B2 (en) Whitening agents and whitening cosmetics
JPH06256140A (en) Beautifying cosmetic
JPS6239511A (en) Cosmetic for preventing aging of skin
JP2824229B2 (en) Skin cosmetics
JP2744485B2 (en) Whitening cosmetics
JP3001942B2 (en) Skin cosmetics
JPS62221611A (en) Skin cosmetic
JPH0733639A (en) Beautifying and whitening cosmetic
JP2671244B2 (en) Whitening cosmetics
JPS60116616A (en) Cosmetic
JPH04352707A (en) Skin cosmetic
JP4116750B2 (en) Cosmetics